Our most comprehensive private health screening package — 70+ biomarkers covering advanced cardiovascular risk, hormone profiles, cancer markers, insulin resistance and nutritional status. Every result is reviewed by a clinician and returned in a comprehensive written report. CQC-registered clinic in the Harley Street Medical Area, no GP referral required.
70+ biomarkers. Clinician-reviewed results. Comprehensive written report.
The Gold Health Screening Blood Test is our most comprehensive package — a 70+ biomarker assessment covering advanced cardiovascular risk markers, detailed hormone profiles, insulin resistance, cancer markers and nutritional analysis. It is designed for patients who want the fullest possible picture of their health, with every result reviewed by a clinician and set out in a comprehensive written report.
The Gold package goes significantly beyond what is available through the NHS or standard private health checks. Advanced markers such as ApoB, Lp(a), HOMA-IR, and omega-3 index are not routinely tested but provide clinically important information about cardiovascular risk, metabolic health, and nutritional status that standard panels miss.
Apolipoprotein B (ApoB) is a stronger predictor of cardiovascular events than LDL cholesterol. Lipoprotein(a) [Lp(a)] is a genetically determined cardiovascular risk factor present in approximately 20% of the population — it is not reduced by statins and requires specific management strategies.
Fasting insulin and HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) detect insulin resistance — the underlying driver of type 2 diabetes, metabolic syndrome, and cardiovascular disease — years before HbA1c becomes abnormal.
The standard TSH test can miss subclinical thyroid dysfunction. The Gold package includes free T3, free T4, and anti-TPO antibodies — identifying autoimmune thyroid disease (Hashimoto's, Graves') and subclinical hypothyroidism that a TSH alone would not detect.
The omega-3 index measures the percentage of EPA and DHA in red blood cell membranes — a validated marker of cardiovascular risk and a guide to dietary supplementation. Low omega-3 index is associated with increased risk of sudden cardiac death and cognitive decline.
Every marker in your Gold panel is reviewed by a Sonoworld clinician before your results are released. Your written report sets each value against its reference range, flags anything outside the expected range, and explains what that finding means in the context of your history.
A detailed clinical history covering your symptoms, risk factors, family history, medications, lifestyle, and health goals. This ensures every result is interpreted in the context of your individual clinical picture.
A trained phlebotomist collects your blood sample — typically 6–8 tubes for the Gold package. The procedure takes approximately 15 minutes in a comfortable, private clinical room.
Your sample is sent to an accredited laboratory and the full Gold panel is processed within 48 hours. You do not need to return to the clinic while your sample is being analysed.
Every result is reviewed by a Sonoworld clinician before release. You receive a comprehensive written report setting out each marker against its reference range, with commentary on any value outside the expected range and guidance on whether further investigation is indicated.
9 biomarker categories, clinician-reviewed written report.
View Bronze — £50030+ biomarkers including a full hormone panel and hsCRP, with a clinician-reviewed written report.
View Silver — £70070+ biomarkers including ApoB, Lp(a), insulin resistance and cancer markers, with a clinician-reviewed written report.
ApoB (apolipoprotein B) is a protein found on all atherogenic (artery-clogging) lipoprotein particles. ApoB is a more accurate predictor of cardiovascular risk than LDL cholesterol because it counts every atherogenic particle — not just the cholesterol content. Many patients with "normal" LDL have elevated ApoB and are at significantly higher cardiovascular risk than their standard cholesterol panel suggests.
Lipoprotein(a) [Lp(a)] is a genetically determined cardiovascular risk factor that is elevated in approximately 20% of the population. High Lp(a) is associated with a 2–4-fold increased risk of heart attack and stroke. It is not reduced by statins or standard lifestyle changes, and requires specific management strategies. Knowing your Lp(a) level allows for more aggressive risk factor management and appropriate specialist referral.
Your report lists every marker tested alongside its reference range, so you can see exactly where each result sits. A Sonoworld clinician reviews the full panel before it is released and flags any value outside the expected range, with commentary on what it may indicate and whether further investigation is advisable.
No. The Gold health screen is a self-referral service, so you can book directly without a GP letter. We do recommend sharing your written report with your GP, particularly if any marker falls outside its reference range, so that your results sit alongside the rest of your medical record.
Yes. Many patients combine the Gold blood test with our Cardiovascular Screening Package (echocardiogram, carotid Doppler, and aortic aneurysm scan) for a comprehensive same-day cardiovascular health assessment. Please call 020 3633 4902 to arrange a combined appointment.
For most patients, an annual Gold health screen provides an excellent longitudinal view of health trends. Patients with specific risk factors or abnormal results on a previous screen may benefit from 6-monthly monitoring of key markers. The clinician reviewing your panel will advise on the appropriate follow-up interval in your written report.
